Collapsing focal segmental glomerulosclerosis following long-term treatment with oral ibandronate: case report and review of literature.

Publication Type:

Journal Article

Source:

BMC cancer, Volume 15, p.535 (2015)

Abstract:

Renal toxicity has been reported with bisphosphonates such as pamidronate and zolidronate but not with ibandronate, in the treatment of breast cancer patients with bone metastasis. One of the patterns of bisphosphonate-induced nephrotoxicity is focal segmental glomerulosclerosis (FSGS) or its morphological variant, collapsing focal segmental glomerulosclerosis (CFSGS).